Genetic Analysis enters a Service Agreement with Eurofins ADME BIOANALYSES – The first CRO to offer the GA-map® Microbiome test
OSLO, NORWAY – 19 October 2021: Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced a Service Agreement with Eurofins ADME BIOANALYSES, a Contract Research Organisation (CRO) providing diverse services to the pharmaceutical industry in the fields of pharmacokinetics, pharmacodynamics and drug metabolism.There is increasing demand for the inclusion of gut microbiome assessments in clinical trials and clinical trial research. Eurofins ADME BIOANALYSES’ launch of GA-map® Dysbiosis Test, a CE marked standardised gut microbiome test by Eurofins ADME BIOANALYSES will